138 related articles for article (PubMed ID: 29263143)
1. MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells.
Zhou X; Chen J; Xiao Q; Wang T; Yu Y; Li B; Shao G; Li Y; Zhang Z
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263143
[TBL] [Abstract][Full Text] [Related]
2. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.
Moore C; Parrish JK; Jedlicka P
PLoS One; 2017; 12(5):e0178028. PubMed ID: 28542597
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion.
Karnuth B; Dedy N; Spieker T; Lawlor ER; Gattenlöhner S; Ranft A; Dirksen U; Jürgens H; Bräuninger A
PLoS One; 2014; 9(3):e93067. PubMed ID: 24667836
[TBL] [Abstract][Full Text] [Related]
4. microRNA and Bone Cancer.
Nugent M
Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
[TBL] [Abstract][Full Text] [Related]
5. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
Fang Y; Sun B; Wang J; Wang Y
Gene; 2019 May; 699():37-42. PubMed ID: 30851425
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway.
Zhang L; Lv Z; Xu J; Chen C; Ge Q; Li P; Wei D; Wu Z; Sun X
FEBS J; 2018 Apr; 285(7):1359-1371. PubMed ID: 29474747
[TBL] [Abstract][Full Text] [Related]
7. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
9. The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.
Parrish JK; Sechler M; Winn RA; Jedlicka P
Oncogene; 2015 Jan; 34(2):257-62. PubMed ID: 24362521
[TBL] [Abstract][Full Text] [Related]
10. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
[TBL] [Abstract][Full Text] [Related]
11. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
Niu J; Sun Y; Guo Q; Niu D; Liu B
Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
[TBL] [Abstract][Full Text] [Related]
12. Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.
Dylla L; Jedlicka P
PLoS One; 2013; 8(4):e63032. PubMed ID: 23638178
[TBL] [Abstract][Full Text] [Related]
13. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
14. MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.
Wang R; Tian S; Wang HB; Chu DP; Cao JL; Xia HF; Ma X
FEBS Lett; 2014 Nov; 588(23):4438-47. PubMed ID: 25448984
[TBL] [Abstract][Full Text] [Related]
15. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Ma X; Wu D; Zhang X; Shao X; Hu G
Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma.
Wang JY; Jiang JB; Li Y; Wang YL; Dai Y
Biomed Pharmacother; 2017 Sep; 93():1047-1054. PubMed ID: 28738498
[TBL] [Abstract][Full Text] [Related]
17. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma.
Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z
Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964
[TBL] [Abstract][Full Text] [Related]
18. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
19. ROCK1-PredictedmicroRNAs Dysregulation Contributes to Tumor Progression in Ewing Sarcoma.
Roberto GM; Delsin LEA; Vieira GM; Silva MO; Hakime RG; Gava NF; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Pathol Oncol Res; 2020 Jan; 26(1):133-139. PubMed ID: 29270775
[TBL] [Abstract][Full Text] [Related]
20. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
